Metoclopramide is recommended for adults with breakthrough or refractory chemotherapy-induced nausea and vomiting (CINV) and for CINV prophylaxis in children. The drug regulatory agencies of Canada and the EU have revised the labelling of metoclopramide to contraindicate its use in children aged <1 year and to caution against its use in children aged <5 years and its duration of use beyond 5 days.
This review describes the safety of metoclopramide in children when given for any indication.
We conducted electronic searches in MEDLINE and Embase as of 9 March 2015. All studies in English reporting adverse effects associated with the use of metoclopramide in children (aged ≤18 years) were included. Adverse effects that had a cumulative incidence of at least 1 % and were reported in prospective studies were synthesized.
A total of 108 (57 prospective) studies involving 2699 patients (2745 metoclopramide courses) were included. The most common adverse effects reported in prospective studies of metoclopramide in children were extrapyramidal symptoms (EPS; 9 %, 95 % confidence interval [CI] 5–17), diarrhea (6 %, 95 % CI 4–9), and sedation (multiple-dose studies: 6 %, 95 % CI 3–12). Dysrhythmia, respiratory distress/arrest, neuroleptic malignant syndrome, and tardive dyskinesia were rarely associated with metoclopramide use.
The definitions of adverse effects reported in the included studies were heterogeneous, and the risk of bias in most studies was moderate.
The most commonly reported adverse effects associated with the use of metoclopramide in children—EPS, diarrhea, and sedation—were reversible and of no long-term significance. Adverse effects that were life threatening or slow to resolve were rarely associated with its use in children.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
National Comprehensive Cancer Network. Antiemesis version 2.2014: National Comprehensive Cancer Network; 2014. Available from: http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed 19 June 2014.
Dupuis LL, Boodhan S, Holdsworth M, Robinson PD, Hain R, Portwine C, et al. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2013;60:1073–82.
Apotex Inc. Apo-Metoclop; Product Monograph. Weston; 2014.
Sandoz Canada Inc. Metoclopramide Hydrochloride Injection; Product Monograph. Boucherville; 2014.
Health Canada. Summary safety review—metoclopramide—abnormal involuntary movements of the body (extrapyramidal symptoms) in children 2015. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/metoclopramide-eng.php. Accessed 17 Aug 2015.
European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/07/WC500146614.pdf. Accessed 17 Aug 2015.
Hayden J, van der Windt D, Cartwright J, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–6.
Carcillo JA, Dean JM, Holubkov R, Berger J, Meert KL, Anand KJ, et al. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med. 2012;13(2):165–73.
Dick GS, Meller ST, Pinkerton CR. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child. 1995;73(3):243–5.
Koseoglu V, Kurekci AE, Sarici U, Atay AA, Ozcan O. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.[Erratum appears in Eur J Pediatr 1999 Feb;158(2):168 Note: Sorici U [corrected to Sarici U]]. Eur J Pediatr. 1998;157(10):806–10.
Marshall G, Kerr S, Vowels M, O’Gorman-Hughes D, White L. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. J Pediatr. 1989;115(1):156–60.
Nicolson R, Craven-Thuss B, Smith J, McKinlay BD, Castellanos FX. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette’s disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(7):640–6.
Tolia V, Calhoun J, Kuhns L, Kauffman RE. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr. 1989;115(1):141–5.
Bellissant E, Duhamel JF, Guillot M, Pariente-Khayat A, Olive G, Pons G. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clin Pharmacol Ther. 1997;61(3):377–84.
Graham-Pole J, Weare J, Engel S, Gardner R, Mehta P, Gross S. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine. J Clin Oncol. 1986;4(7):1110–3.
Leblanc TM, Da Costa L, Marie I, Demolis P, Tchernia G. Metoclopramide treatment in DBA patients: no complete response in a French prospective study. Blood. 2007;109(5):2266–7.
Machida HM, Forbes DA, Gall DG, Scott RB. Metoclopramide in gastroesophageal reflux of infancy. J Pediatr. 1988;112(3):483–7.
Miyajima Y, Numata SI, Katayama I, Horibe K. Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol. 1994;16(3):236–41.
Van Eygen M, Dhondt F, Heck E, Ameryckx L, Van Ravensteyn H. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. Postgrad Med J. 1979;55(Suppl 1):36–9.
Al-Ansari K, Alomary S, Abdulateef H, Alshawagfa M, Kamal K. Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis. J Pediatr Gastroenterol Nutr. 2011;53(2):156–60.
Basade M, Kulkarni SS, Dhar AK, Sastry PS, Saikia B, Advani SH. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy. Indian Pediatr. 1996;33(4):321–3.
Cubeddu LX, Trujillo LM, Talmaciu I, Gonzalez V, Guariguata J, Seijas J, et al. Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther. 1997;11(1):185–91.
Daftary S, Jagtap SR, Saksena S. Intravenous ondansetron in prevention of PONV following tonsillectomy under ether anaesthesia. J Anaesthesiol Clin Pharmacol. 1998;14(1):51–4.
Ferrari LR, Donlon JV. Metoclopramide reduces the incidence of vomiting after tonsillectomy in children. Anesth Analg. 1992;75(3):351–4.
Forbes D, Hodgson M, Hill R. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr. 1986;5(4):556–9.
Swann IL, Thompson EN, Qureshi K. Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting. Br Med J. 1979;2(6199):1188.
Bolton CM, Myles PS, Carlin JB, Nolan T. Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy. Br J Anaesth. 2007;99(5):699–703.
Broadman LM, Ceruzzi W, Patane PS, Hannallah RS, Ruttimann U, Friendly D. Metoclopramide reduces the incidence of vomiting following strabismus surgery in children. Anesthesiology. 1990;72(2):245–8.
Fujii Y, Tanaka H. Comparison of granisetron, droperidol, and metoclopramide for prevention of postoperative vomiting in children with a history of motion sickness undergoing tonsillectomy. J Pediatr Surg. 2001;36(3):460–2.
Furst SR, Rodarte A. Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy. Anesthesiology. 1994;81(4):799–803.
Lee JS, Jeon WC, Park EJ, Min YG, Jung YS, Kim GW, et al. Adjunctive atropine versus metoclopramide: can we reduce ketamine-associated vomiting in young children? A prospective, randomized, open, controlled study. Acad Emerg Med. 2012;19(10):1128–33.
Lin DM, Furst SR, Rodarte A. A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery. Anesthesiology. 1992;76(3):357–61.
Rose JB, McCloskey JJ. Rapid intravenous administration of ondansetron or metoclopramide is not associated with cardiovascular compromise in children. Paediatr Anaesth. 1995;5(2):121–4.
Liu YC, Kang HM, Liou CM, Tso HS. Comparison of antiemetic effect among ephedrine, droperidol and metoclopramide in pediatric inguinal hernioplasty. Ma Tsui Hsueh Tsa Chi. 1992;30(1):37–41.
Luisi FA, Petrilli AS, Tanaka C, Caran EM. Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. Sao Paulo Med J. 2006;124(2):61–5.
Pendeville PE, Veyckemans F, Van Boven MJ, Steinier JR. Open placebo controlled comparison of the antiemetic effect of droperidol, metoclopramide or a combination of both in pediatric strabismus surgery. Acta Anaesthesiol Belg. 1993;44(1):3–10.
Ram D, Mamber E, Chosack A, Fuks AB. The effect of metoclopramide and hydroxyzine in sedation of infants undergoing dental treatment. J Dent Child. 1999;66(1):49–52, 13.
Shende D, Haldar M. Prophylactic metoclopramide administered immediately after the induction of anesthesia has no effect on the incidence of postoperative emesis after strabismus surgery. Indian Pediatr. 1998;35(3):237–41.
Shende D, Mandal NG. Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children. Anaesthesia. 1997;52(5):496–500.
Christensen S, Farrow-Gillespie A, Lerman J. Effects of ranitidine and metoclopramide on gastric fluid pH and volume in children. Br J Anaesth. 1990;65(4):456–60.
El-Basousy MM, Khashaba AA, Hafez M, Mohareb SW, Abdel Gawdd MA, Mancy F. Radiological changes in the small intestine of children in bilharziasis. Gaz Egypt Paediatr Assoc. 1973;21(4):33–42.
Fry EN, Ibrahim AA. Hypglycaemia in paediatric anaesthesia: The influence of metoclopramide and oral maltose in paediatric surgical patients. Anaesthesia. 1976;31(4):552–4.
Fujii Y, Tanaka H, Ito M. Treatment of vomiting after paediatric strabismus surgery with granisetron, droperidol, and metoclopramide. Ophthalmologica. 2002;216(5):359–62.
Hyman PE, Abrams C, Dubois A. Effect of metoclopramide and bethanechol on gastric emptying in infants. Pediatr Res. 1985;19(10):1029–32.
Hyman PE, Abrams CE, Dubois A. Gastric emptying in infants: response to metoclopramide depends on the underlying condition. J Pediatr Gastroenterol Nutr. 1988;7(2):181–4.
Kathirvel S, Shende D, Madan R. Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus. Eur J Anaesthesiol. 1999;16(11):761–5.
Suga A, Tanaka M, Toyooka H. Effects of i.v. metoclopramide, atropine and their combination on gastric insufflation in children anaesthetized with sevoflurane and nitrous oxide. Paediatr Anaesth. 2001;11(2):151–6.
Zatman TF, Hall JE, Harmer M. Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents. Br J Anaesth. 2001;86(6):869–71.
Acosta MT, Castellanos FX. Use of the “inverse neuroleptic” metoclopramide in Tourette syndrome: an open case series. J Child Adolesc Psychopharmacol. 2004;14(1):123–8.
Allen JC, Gralla R, Reilly L, Kellick M, Young C. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol. 1985;3(8):1136–41.
Cameron PF. Strained abdominal muscles as a cause of acute abdominal pain in children and young adults and its treatment with Paramax. Br J Clin Pract. 1983;37(5):178–80.
Heimann G, Roth B, Gladtke E. The age-dependence of intestinal absorption using d-xylose as an example. Eur J Pediatr. 1977;124(4):285–94.
Hitch DC, Vanhoutte JJ, Torres-Pinedo RB. Enhanced gastroduodenal motility in children. Am J Dis Child. 1982;136(4):299–302.
Howrie DL, Felix C, Wollman M, Juhl RP, Blatt J. Metoclopramide as an antiemetic agent in pediatric oncology patients. Drug Intell Clin Pharm. 1986;20(2):122–4.
Kearns GL, Butler HL, Lane JK, Carchman SH, Wright GJ. Metoclopramide pharmacokinetics and pharmacodynamics in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 1988;7(6):823–9.
Leung AKC, Lai PCW. Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children. Curr Ther Res Clin Exp. 1984;36(5 I):911–5.
Subramanian V, Soundararajan V, Viswanathan J. Metoclopramide (perinorm) in children. (Report of trial in cases with nausea and vomiting). Antiseptic. 1980;77(4):211–2.
Terrin BN, McWilliams NB, Maurer HM. Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatr. 1984;104(1):138–40.
Bateman DN, Craft AW, Nicholson E, Pearson AD. Dystonic reactions and the pharmacokinetics of metoclopramide in children. Br J Clin Pharmacol. 1983;15(5):557–9.
Gaze H, Rolles C, Signer E, Sagaro E. Premedication for jejunal biopsy in childhood using intravenous diazepam and metoclopramide. Arch Dis Child. 1974;49(4):322–4.
Harris MJ, Harrington G, Beveridge J. Modification to the technique for small bowel biopsy in children: including the use of metoclopramide. Am J Dis Child. 1968;115(1):43–7.
Hyams JS, Leichtner AM, Zamett LO, Walters JK. Effect of metoclopramide on prolonged intraesophageal pH testing in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 1986;5(5):716–20.
Pons G, Duhamel JF, Guillot M, Gouyon JB, d’Athis P, Richard MO, et al. Dose-response study of metoclopramide in gastroesophageal reflux in infancy. Fundam Clin Pharmacol. 1993;7(3–4):161–6.
Rode H, Stunden RJ, Millar AJ, Cywes S. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide. J Pediatr Surg. 1987;22(10):931–4.
Al Zaben AA, Al Herbish AS. Neurological side effects associated with unnecessary use of metoclopramide in children. Ann Saudi Med. 1995;15(2):183–4.
Boulloche J, Mallet E, Mouterde O, Tron P. Dystonic reactions with metoclopramide: is there a risk population? Helv Paediatr Acta. 1987;42(5–6):425–32.
Lifshitz M, Gavrilov V. Adverse reactions to metoclopramide in young children: a 6-year retrospective study and review of the literature. J Pharm Technol. 2002;18(3):125–7.
Nahata MC, Kniska KS. Clinical usage of medications in infants and children with gastroesophageal reflux. J Appl Ther. 1997;1(3):243–6.
Rodriguez L, Irani K, Jiang H, Goldstein AM. Clinical presentation, response to therapy, and outcome of gastroparesis in children. J Pediatr Gastroenterol Nutr. 2012;55(2):185–90.
Stenhammar L, Warngard O, Lewander P, Nordvall M. Oral versus intravenous premedication for small bowel biopsy in children: effect on procedure and fluoroscopy times. Acta Paediatr. 1993;82(1):49–51.
Casteels-Van Daele M, Jaeken J. Primperan and its side-effects. Tijdschr Gastroenterol. 1971;14(3):205–15.
Gupte S. Dystonic reactions following metoclopramide therapy. Indian J Pediatr. 1982;49(397):291–2.
Menniti-Ippolito F, Traversa G, Da Cas R, Rossi R, Renna S, Barabino P, et al. Extrapyramidal reactions in children treated with metoclopramide. Ital J Pediatr. 2004;30(1):49–52.
Moussa MAA, El-Hait SAS, Al-Khars A. Dystonic reactions to metoclopramide and prochlorperazine in children. J Kuwait Med Assoc. 1984;18(2):75–9.
Arumugam J, Vijayalakshmi AM. Metoclopramide-induced oculogyric crisis presenting as encephalitis in a young girl. Indian J Pharmacol. 2012;44(2):266–7.
Fradkin A, Yahav J, Jonas A. Severe respiratory distress following premedication for small intestinal biopsy. Isr J Med Sci. 1990;26(7):412–3.
Kofoed PE, Kamper J. Extrapyramidal reactions caused by antiemetics during cancer chemotherapy. J Pediatr. 1984;105(5):852–3.
Lou E, Abou-Zeid N. A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis. South Med J. 2006;99(11):1290–1.
Newton-John H. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. Bmj. 1988;297(6654):964–5.
Shaw A, Matthews EE. Postoperative neuroleptic malignant syndrome. Anaesthesia. 1995;50(3):246–7.
Sreevastava D, Garcha P, Prabhakar T, Mukherjee D, Divekar D. Metoclopramide and respiratory arrest. J Anaesth Clin Pharmacol. 1996;13:81–9.
Tait PA. Supraglottic dystonic reaction to metoclopramide in a child. Med J Aust. 2001;174(11):607–8.
Doss M, Becker U, Peter HJ, Kaffarnik H. Drug safety in porphyria: risks of valproate and metoclopramide. Lancet. 1981;2(8237):91.
Gatrad AR, Gatrad AH. Familial incidence of dystonic reactions to metoclopramide (maxolon). Br J Clin Pract. 1979;33(4):111, 5.
Ghirga G, Ghirga P, Palazzi C, Presti A. Chlorpheniramine I.M. and I.V. promptly relieved dystonic symptoms caused by metoclopramide in two children. Rivista di Tossicologia Sperimentale e Clinica. 1991;21(1):41–9.
Guala A, Mittino D, Fabbrocini P, Ghini T. Familial metoclopramide-induced dystonic reactions. Mov Disord. 1992;7(4):385–6.
Incecik F, Onlen Y, Ozer C, Ozcan K. Metoclopramide induced acute dystonic reaction: two case reports. Marmara Med J. 2008;21(2):159–61.
Isikay S, Almacioglu M, Yilmaz K. Metoclopramide induced acute dystonic reaction in a child: a case report. Akademik Acil Tip Olgu Sunumlari Dergisi. 2012;3(2):59–61.
Khaledi M, Suda K, Shelton C. Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. Int J Clin Pharm. 2012;34:822–4.
Koban Y, Ekinci M, Cagatay HH, Yazar Z. Oculogyric crisis in a patient taking metoclopramide. Clin Ophthalmol. 2014;8:567–9.
Kohli-Kumar M, Pearson AD, Sharkey I, Craft AW. Urinary retention–an unusual dystonic reaction to continuous metoclopramide infusion. DICP. 1991;25(5):469–70.
Langford JS, Sheikh S. An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine. Ann Emerg Med. 1999;34(4 Pt 1):538–41.
Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005;20(1):86–9.
Palop V, Jimenez MJ, Catalan C, Martinez-Mir I. Acute dystonia associated with fluvoxamine-metoclopramide. Ann Pharmacother. 1999;33(3):382.
Paturi B, Ryan RM, Michienzi KA, Lakshminrusimha S. Galactorrhea with metoclopramide use in the neonatal unit. J Perinatol. 2009;29(5):391–2.
Ponte CD. Metoclopramide in the treatment of an infant with gastroesophageal hypomotility. Drug Intell Clin Pharm. 1982;16(12):965–6.
Putnam PE, Orenstein SR, Wessel HB, Stowe RM. Tardive dyskinesia associated with use of metoclopramide in a child. J Pediatr. 1992;121(6):983–5.
Reid M. Dystonic reactions to metoclopramide (maxolon). Ulster Med J. 1977;46(1):38–40.
Sahin B, Turkmen MA, Kavukcu S. Iatrogenic metoclopramide toxicity in an infant presenting to a pediatric emergency department. Pediatr Emerg Care. 2001;17(2):150–1.
Shafrir Y, Levy Y, Beharab A. Acute dystonic reaction to bethanechol, a direct acetylcholine receptor agonist. Dev Med Child Neurol. 1986;28(5):646–8.
Silfeler I, Arica V, Arica S, Dogan M. Development of acute dystonia in three brothers due to metoclopramide. J Res Med Sci. 2012;17(3):68–9.
Sills JA, Glass EJ. Metoclopramide in young children. Br Med J. 1978;2(6134):431.
Stoddart JC. Pseudotetanus. Anaesthesia. 1979;34(9):877–81.
Upham JW. Dystonic reaction to metoclopramide. Med J Aust. 1983;1(1):12.
Wandless I, Evans JG, Jackson M. Fever associated with metoclopramide-induced dystonia. Lancet. 1980;1(8180):1255–6.
Wood GD. An adverse reaction to metoclopramide therapy. Br J Oral Surg. 1978;15(3):278–80.
Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced dystonia in children: two case reports. Eur J Emerg Med. 2005;12(3):117–9.
Brower R, Dreyer C, Kent T. Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea. J Child Neurol. 1989;4:230–2.
Caksen H, Atas B, Tuncer O, Odabas D. Severe generalized dystonia induced by metoclopramide in a girl with methylmalonic acidemia. Brain Dev. 2003;25(2):144–5.
Casteels-Van Daele M. Reye syndrome or side-effects of anti-emetics? Eur J Pediatr. 1991;150(7):456–9.
Daneshmend TK, Manning AP. Metoclopramide induced dystonic reactions misdiagnosed as hysteria. Br J Clin Pract. 1978;32(11):334–6.
De Silva KL, Muller PJ, Pearce J. Acute drug-induced extrapyramidal syndromes. Practitioner. 1973;211(263):316–20.
Balamtekin N, Gulgun M, Sarici SU, Unay B, Dundaroz MR. Metoclopramide induced intermittent opisthotonos in infant. Cent Eur J Med. 2010;5(2):224–6.
Batts KF, Munter DW. Metoclopramide toxicity in an infant. Pediatr Emerg Care. 1998;14(1):39–41.
Low LC, Goel KM. Metoclopramide poisoning in children. Arch Dis Child. 1980;55(4):310–2.
European Medicines Agency. Assessment report: metoclopramide only containing medicinal products. London: Canary Wharf; 2013.
Mehta S, Morgan J, Sethi K. Drug-induced movement disorders. Neurology. Clinics. 2015;33:153–74.
Cavero-Redondo I, Alvarez-Bueno C, Pozuelo-Carrascosa D, Diez-Fernandez A, Notario-Pacheco B. Risk of extra-pyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials. J Clin Nurs. 2015. doi:10.1111/jocn.12984.
The assistance of Ms. Elizabeth Uleryk, Library Scientist, with the literature search and the administrative assistance of Ms. Sandra Cabral are gratefully acknowledged.
Support of the Pediatric Oncology Group of Ontario to conduct the study and to prepare the manuscript is acknowledged. The funder did not influence the interpretation of the results of this work.
Conflict of interest
Melissa Lau Moon Lin, Paula D. Robinson, Jacqueline Flank, Lillian Sung, and L. Lee Dupuis have no conflicts of interest that are directly relevant to the content of this study.
Electronic supplementary material
About this article
Cite this article
Lau Moon Lin, M., Robinson, P.D., Flank, J. et al. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf 39, 675–687 (2016). https://doi.org/10.1007/s40264-016-0418-9
- Tardive Dyskinesia
- Neuroleptic Malignant Syndrome